Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
BMJ publishes medical journals and evidence summaries that help doctors and healthcare professionals make better decisions.
BMJ is a medical publisher. It makes its money by selling journals, clinical decision tools, and medical education to doctors, hospitals, and health systems. Its most famous product is The BMJ (formerly the British Medical Journal), one of the world's oldest and most respected general medical journals, which has been published since 1840. But the modern business is much more than a magazine โ it's a package of tools that help a busy doctor answer a specific question fast.
The core of that package is evidence-based medicine. The idea sounds obvious now, but BMJ helped pioneer it: instead of relying on habit or authority, doctors should base decisions on the best available research. BMJ's clinical tools, like BMJ Best Practice, take the latest research and turn it into short, practical guidance a doctor can consult mid-consultation โ what to test, what to prescribe, when to worry. Hospitals and medical schools pay for site-wide access, and that recurring institutional money is the backbone of the business. BMJ also runs a family of specialist journals covering fields from heart health to gastroenterology to public health, plus a growing portfolio of medical education and quality-improvement services. It is owned by the British Medical Association, the UK doctors' union โ so it answers to doctors rather than to shareholders, which shapes its reputation for independence. Its main competitors are other medical publishers and clinical-reference providers, notably Elsevier and Wolters Kluwer, which sell rival research databases and point-of-care tools.
The business faces real pressure. Open-access publishing, where authors pay to make research free to read, has upended the traditional subscription model across medical publishing. And free or cheap AI tools can now summarize research in seconds, which threatens the simple "look it up" value of a reference product. BMJ's bet is that doctors will pay for trusted, curated, editorially reviewed answers โ not just fast ones. That trust, built over more than 180 years, is its main asset and its main defense.
Saved answer ยท last researched 16 Nov 2026